Platelet-derived growth factor receptor-induced feed-forward inhibition of excitatory transmission between hippocampal pyramidal neurons

J Biol Chem. 1999 Oct 22;274(43):30617-23. doi: 10.1074/jbc.274.43.30617.

Abstract

Growth factor receptors provide a major mechanism for the activation of the nonreceptor tyrosine kinase c-Src, and this kinase in turn up-regulates the activity of N-methyl-D-aspartate (NMDA) receptors in CA1 hippocampal neurons (1). Unexpectedly, applications of platelet-derived growth factor (PDGF)-BB to cultured and isolated CA1 hippocampal neurons depressed NMDA-evoked currents. The PDGF-induced depression was blocked by a PDGF-selective tyrosine kinase inhibitor, by a selective inhibitor of phospholipase C-gamma, and by blocking the intracellular release of Ca(2+). Inhibitors of cAMP-dependent protein kinase (PKA) also eliminated the PDGF-induced depression, whereas a phosphodiesterase inhibitor enhanced it. The NMDA receptor-mediated component of excitatory synaptic currents was also inhibited by PDGF, and this inhibition was prevented by co-application of a PKA inhibitor. Src inhibitors also prevented this depression. In recordings from inside-out patches, the catalytic fragment of PKA did not itself alter NMDA single channel activity, but it blocked the up-regulation of these channels by a Src activator peptide. Thus, PDGF receptors depress NMDA channels through a Ca(2+)- and PKA-dependent inhibition of their modulation by c-Src.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Becaplermin
  • Calcium / metabolism
  • Cells, Cultured
  • Cyclic AMP-Dependent Protein Kinases / pharmacology
  • Enzyme Activation
  • Enzyme Inhibitors / pharmacology
  • Estrenes / pharmacology
  • Evoked Potentials / drug effects
  • Heparin / pharmacology
  • Hippocampus / physiology*
  • Homeostasis
  • In Vitro Techniques
  • Isoenzymes / metabolism
  • Mice
  • N-Methylaspartate / pharmacology
  • Patch-Clamp Techniques
  • Peptide Fragments / pharmacology
  • Phospholipase C gamma
  • Platelet-Derived Growth Factor / pharmacology*
  • Protein-Tyrosine Kinases / metabolism
  • Proto-Oncogene Proteins c-sis
  • Pyramidal Cells / physiology*
  • Pyridines / pharmacology
  • Pyrrolidinones / pharmacology
  • Rats
  • Rats, Wistar
  • Receptors, Platelet-Derived Growth Factor / physiology*
  • Synaptic Transmission / drug effects
  • Synaptic Transmission / physiology*
  • Type C Phospholipases / metabolism

Substances

  • Enzyme Inhibitors
  • Estrenes
  • Isoenzymes
  • Peptide Fragments
  • Platelet-Derived Growth Factor
  • Proto-Oncogene Proteins c-sis
  • Pyridines
  • Pyrrolidinones
  • WIN 41662
  • 1-(6-((3-methoxyestra-1,3,5(10)-trien-17-yl)amino)hexyl)-1H-pyrrole-2,5-dione
  • U 73343
  • Becaplermin
  • N-Methylaspartate
  • Heparin
  • Protein-Tyrosine Kinases
  • Receptors, Platelet-Derived Growth Factor
  • Cyclic AMP-Dependent Protein Kinases
  • Type C Phospholipases
  • Phospholipase C gamma
  • Calcium